Publications
Inivata actively publishes and presents new data. Please find a full listing below by year.
Featured Publication
Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer
Event name - Journal of Clinical Oncology
Marla Lipsyc-Sharf, MD Elza C. de Bruin, PhD Katheryn Santos, BS Robert McEwen, PhD Daniel Stetson, MS Ashka Patel, BS Gregory J. Kirkner, MPH Melissa E. Hughes, MSc Sara M. Tolaney, MD, MPH Ann H. Partridge, MD, MPH Ian E. Krop, MD, PhD ... Read More
Comparison of a personalized sequencing assay and digital PCR for circulating tumor DNA based Molecular Residual Disease detection in early-stage triple negative breast cancer in the cTRAK-TN trial
Event name - SABCS2022
Maria Coakley, Prithika Sritharan, Guillermo Villacampa, Claire Swift, Kathryn Dunne, Lucy Kilburn, Katie Goddard, Patricia Rojas, Andy Joad, Warren Emmett, Charlene Knape, Karen Howarth, Peter Hall, Catherine Harper-Wynne, Tamas Hickish, Iain Macpherson, Alicia Okines, Andrew Wardley, Duncan Wheatley, Simon Waters, Rosalind J Cutts, Isaac Garcia-Murillas, Judith Bliss, Nicholas C Turner Read More
Circulating Tumour DNA (ctDNA) Detection and Dynamics in Patients with Early Breast Cancer (EBC): Results of the Neoadjuvant TRACER cohort
Event name - SABCS2022
Mitchell J. Elliott, Zach Veitch, Philippe Elichard, Philippe L. Bedard, Eitan Amir, Aaron Dou, Jesús Fuentes Antrás, Michelle B. Nadler, Nicholas Meti, Nancy Gregorio, Elizabeth Shah, Helen Chow, Nathan Campbell, Samantha Terrell, Charlene Knape, Karen Howarth, Lillian L. Siu, Hal K. Berman, David W. Cescon Read More
Development of a Standardized, DNA-Based Next-Generation Sequencing Assay for Assessment of Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)
Event name - ASH2022
Luis A. Carvajal, Tressa Hood, Yana Bevan, Richard Dillon, Nicola Potter, Ian Thomas, Sean Johnson, JadOthman, Amanda Gilkes, Nigel Russell, Adam Sikorski, Pete Ellis, Giovanni Marsico, Greg Jones, Crystal MacKenzie, Zung To, Jorge DiMartino, Pavan Kumar Read More
Liquid biopsy for detection of molecular residual disease and recurrence in head and neck squamous cell carcinoma
Event name - ESMO2022
Susanne Flach, Karen Howarth, Sophie Hackinger, Christodoulos Pipinikas, Pete Ellis, Kirsten McLay, Giovanni Marsico, Patricia Rojas, Christoph Walz, Lukas Käsmann, Axel Lechner, Christoph A. Reichel, Olivier Gires, Martin Canis, Philipp Baumeister Read More
Updated follow-up data and biomarker analysis of pre-operative ipilimumab and nivolumab in locoregional advanced urothelial cancer (NABUCCO)
Event name - ESMO2022
C.F. Stockem, A. Gil-Jimenez, J. Van Dorp, N. Van Dijk, M. Alkemade, I.M. Seignette, C. Pipinikas, G. Jones, G. Marsico, S. Hackinger, N. Rosenfeld, M.L. Van Montfoort, B.W.G. van Rhijn, K. Hendricksen, J.M. de Feijter, R.P. Meijer, A.G. van der Heijden, L.F.A. Wessels, N. Mehra, B.B.M. Suelmann, M.S. van der Heijden Read More
Plasma First – Accelerating Lung Cancer Diagnosis through Liquid Biopsy
Event name - ASCO2022
Miguel Garcia-Pardo, Kasia Czarnecka, Jennifer H. Law, Alexandra Salvarrey, Roxanne Fernandes, Jason Fan, Lucy Corke, Lisa W. Le, Thomas K. Waddell, Kazuhiro Yasufuku, Geoffrey Liu, Frances A. Shepherd, Penelope Bradbury, Adrian Sacher, Tracy Stockley, Prodipto Pal, Ming Sound Tsao, Karen Howarth, Christodoulos Pipinikas, Natasha B. Leighl Read More
Liquid bIOpsy for miNimal rESidual diSease detection in Head and Neck Squamous Cell Carcinoma (LIONESS) – A personalized cell-free tumor DNA analysis for patients with HNSCC
Event name - ASCO2022
Susanne Flach, Karen Howarth, Sophie Hackinger, Christodoulos Pipinikas, Pete Ellis, Kirsten McLay, Giovanni Marsico, Christoph Walz, Olivier Gires, Martin Canis, Philipp Baumeister Read More
Leveraging personalized circulating tumor DNA (ctDNA) for detection and monitoring of molecular residual disease in high-risk melanoma
Event name - ASCO2022
Sofia Genta, Daniel V Araujo, Sareh Keshavarzi, Thiago P Muniz, Zaid Saeed Kamil, Karen Howarth, Samantha Terrell, Andy Joad, Robert Ventura, Andrea Covelli, Samuel Saibil, Pavlina Spiliopoulou, Olga Vornicova, Alexandra Easson, Marcus Butler, Lillian L Siu, Scott Bratman, Anna Spreafico Read More
Personalized circulating tumor DNA (ctDNA) analysis in patients with recurrent/metastatic Head & Neck Squamous Cell Cancer (R/M HNSCC)
Event name - ASCO2022
Kirsty Taylor, Jinfeng Zou, Marcos Magalhaes, Karen Howarth, Giovanni Marsico, Samantha Terrell, Greg Jones, Charlene Knape, Tim Forshew, Marc Oliva, Anna Spreafico, Aaron R. Hansen, Simon S. McDade, Vicky M. Coyle, Mark Lawler, Elena Elimova, Scott V. Bratman, Lillian L. Siu Read More
Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer
Event name - Annals of Oncology
D. Gale, K. Heider, A. Ruiz-Valdepenas, S. Hackinger, M. Perry, G. Marsico, V. Rundell, J. Wulff, G. Sharma, H. Knock, J. Castedo, W. Cooper, H. Zhao, C.G. Smith, S. Garg, S. Anand, K. Howarth, D. Gilligan, S.V. Harden, D.M. Rassl, R.C. Rintoul, N. Rosenfeld Read More
Predicting pathological response after ipilimumab plus nivolumab in stage III urothelial cancer by liquid biopsy assessment of plasma and urine ctDNA using the RaDaR assay
Event name - AACR2022
Jeroen van Dorp, Christodoulos Pipinikas, Nick van Dijk, Greg Jones, Alberto Gil-Jimenez, Giovanni Marsico, Maurits L. van Montfoort, Sophie Hackinger, Linde Braaf, Kirsten McLay, Daan van den Broek, Bas W.G. van Rhijn, Nitzan Rosenfeld, Michiel S. van der Heijden Read More
Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)—a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma
Event name - British Journal of Cancer 2022
Susanne Flach, Karen Howarth, Sophie Hackinger, Christodoulos Pipinikas, Pete Ellis, Kirsten McLay, Giovanni Marsico, Tim Forshew, Christoph Walz, Christoph A. Reichel, Olivier Gires, Martin Canis, Philipp Baumeister Read More
Exploitation of treatment induced tumor lysis to enhance the sensitivity of ctDNA analysis: a first-in-human pilot study
Event name - Lung Cancer 2022
Daniel A. Breadner, Mark D. Vincent, Rohann Correa, Morgan Black, Andrew Warner, Michael Sanatani, Vasudeva Bhat, Clive Morris, Greg Jones, Alison Allan, David A. Palma, Jacques Raphael Read More
Liquid biopsies for residual disease and recurrence
Event name - Med CellPress 2021
Jonathan Chee Ming Wan, Tariq Imdadali Mughal, Pedram Razavi, Sarah-Jane Dawson, Esther Louise Moss, Ramaswamy Govindan, Iain Beehuat Tan, Yoon-Sim Yap, William Allen Robinson, Clive Dylan Morris, Benjamin Besse, Alberto Bardelli, Jeanne Tie, Scott Kopetz and Nitzan Rosenfeld Read More
Detection of early-stage breast cancer recurrence using a personalised liquid biopsy-based sequencing approach
Event name - San Antonio Breast Cancer Symposium 2021
Wolfgang Janni, Jens Huober, Sophia Huesmann, Christodoulos Pipinikas, Tatjana Braun, Volkmar Müller, Giovanni Marsico, Angelina Fink, Paula Freire-Pritchett, Karin Koretz, Charlene Knape, Amelie de Gregorio, Brigitte Rack, Thomas WP Friedl, Lisa Wiesmüller, Peter Möller, Karen Howarth, Klaus Pantel, Nitzan Rosenfeld Read More
Peripheral immune subsets and circulating tumor DNA (ctDNA) in patients (pts) with residual triple negative breast cancer (TNBC) treated with adjuvant immunotherapy and/or chemotherapy (chemo): The OXEL study
Event name - San Antonio Breast Cancer Symposium 2021
Filipa Lynce, Candace Mainor, Xue Geng, Greg Jones, Ilana Schlam, Hongkun Wang, Ute Feger, Renee Donahue, Nicole Toney, Caroline Jochems, Jeffrey Schlom, Christopher Gallagher, Rita Nanda, Deena Graham, Erica M Stringer-Reasor, Neelima Denduluri, Julie Collins, Asma A Dilawari, Ami Chitalia, Shruti Tiwari, Raquel Nunes, Rebecca Kaltman, Katia Khoury, Margaret Gatti-Mays, Sandra M Swain, Heather A. Parsons, Paula Pohlmann, Claudine Isaacs Read More
A personalised sequencing approach for liquid biopsy-based detection of recurrent disease in early-stage breast cancer
Event name - ESMO21
Wolfgang Janni, Jens Huober, Sophia Huesmann, Christodoulos Pipinikas, Tatjana Braun, Volkmar Müller, Giovanni Marsico, Angelina Fink, Paula Freire-Pritchett, Karin Koretz, Charlene Knape, Amelie de Gregorio, Brigitte Rack, Thomas WP Friedl, Lisa Wiesmueller, Peter Möller, Karen Howarth, Klaus Pantel, Nitzan Rosenfeld Read More
Personalised circulating cell-free tumour DNA analysis for detection of minimal residual disease and recurrence in patients with head and neck squamous cell carcinoma
Event name - ESMO21
Susanne Flach, Karen Howarth, Sophie Hackinger, Christodoulos Pipinikas, Pete Ellis, Kirsten McLay, Giovanni Marsico, Christoph Walz, Olivier Gires, Martin Canis, Philipp Baumeister Read More
Real time clinical utility of ctDNA genomic alterations in untreated patients with advanced NSCLC
Event name - ESMO21
M. Garciade Herreros, S .Muñoz, C. Teixidó, V. Díez, A. Arcocha1, C. Pipinikas, D. Martinez, S. Castillo, R. Reyes, M. Riudavets, E. Auclin, E. Marín, K. Howarth, D. Martínez, J. A. Puig, A. Prat, N. Reguart, N. Viñolas, L. Mezquita Read More
Clinical utility of ctDNA for detection of EGFR, ALK, BRAFV600E alterations and resistance mutations in patients with NSCLC at failure to targeted therapy
Event name - ESMO21
M. Riudavets, D. Vasseur, M. Aldea, V. Lamberts, M. Dorta, C. Naltet, C. Jovelet, M. Grecea, P. Martin-Romano, L. Lacroix, P. Lavaud, A. Gazzah, C. Morris, K. Howarth, F. Barlesi, J-C. Soria C. Massard, D. Planchard, B. Besse, L. Mezquita Read More
Preliminary results of the Liquid Biopsy for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS) study
Event name - EACR 2021
Susanne Flach, Karen Howarth, Sophie Hackinger, Christodoulos Pipinikas, Kirsten McLay, Giovanni Marsico, Christoph Walz, Olivier Gires, Martin Canis, Philipp Baumeister Read More
Residual ctDNA after treatment predicts early relapse in patients with early stage NSCLC
Event name - ASCO 2021
Davina Gale, Cancer Research UK Cambridge Institute, University of Cambridge, on behalf of the LUCID study team Read More
Radiogenomic Analysis of Locally Advanced Lung Cancer Based on CT Imaging and Intratreatment Changes in Cell-Free DNA
Event name - Radiology: Imaging Cancer
Kyle J. Lafata , Michael N. Corradetti, Junheng Gao, Corbin D. Jacobs, Jingxi Weng, Yushi Chang, Chunhao Wang, Ace Hatch, Eric Xanthopoulos, Greg Jones, Chris R. Kelsey and Fang-Fang Yin Read More
Molecular Residual Disease detection in early stage breast cancer with a personalized sequencing approach
Event name - AACR 2021
Rosalind Cutts, Maria Coakley, Isaac Garcia-Murillas, Lara Ulrich, Karen Howarth, Warren Emmett, Malcolm Perry, Pete Ellis, Charlene Knape, Stephen R. D. Johnston, Alistair Ring, Simon Russell, Abigail Evans, Anthony Skene, Duncan Wheatley, Mitch Dowsett, Ian E. Smith, Nicholas C. Turner Read More
Personalized circulating tumor DNA analysis in head and neck squamous cell carcinoma: preliminary results of the Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS) study
Event name - AACR 2021
Susanne Flach, Karen Howarth, Sophie Hackinger, Christodoulos Pipinikas, Kirsten McLay, Giovanni Marsico, Christoph Walz, Olivier Gires, Martin Canis, Philipp Baumeister Read More
Resistance mechanisms to BRAF inhibition identified by single circulating tumor cell and cell-free tumor DNA molecular profiling in BRAF-mutant non-small-cell lung cancer
Event name - AACR 2021
Laura Mezquita, Marianne Oulhen, Agathe Aberlenc, Marc Deloger, Aurélie Honoré, Marianna Garonzi, Genny Buson, Claudio Forcato, Yann Lecluse, Mihaela Aldea, Maud NgoCamus, Claudio Nicotra, Karen Howarth, Ludovic Lacroix, Luc Friboulet, Benjamin Besse, Nicolò Manaresi, David Planchard, Françoise Farace Read More
Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma
Event name - Cancers 2021
Chul Kim, Liqiang Xi, Constance M. Cultraro, Fang Wei, Gregory Jones, Jordan Cheng, Ahmad Shafiei, Trinh Hoc-Tran Pham, Nitin Roper, Elizabeth Akoth, Azam Ghafoor, Vikram Misra, Nina Monkash, Charles Strom, Michael Tu, Wei Liao, David Chia, Clive Morris, Seth M. Steinberg, Hadi Bagheri, David T. W. Wong, Mark Raffeld and Udayan Guha Read More
Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC)
Event name - J Immunother Cancer
Biagio Ricciuti , Greg Jones , Mariano Severgnini , Joao V Alessi , Gonzalo Recondo , Marissa Lawrence , Tim Forshew , Christine Lydon , Mizuki Nishino , Michael Cheng , Mark Awad Read More
Circulating tumor DNA (ctDNA) clearance as a biomarker in patients with locally advanced NSCLC following chemoradiation
Event name - 2020 (Rescheduled) World Conference on Lung Cancer Singapore
B. Knapp, L. Mezquita, S. Devarakonda, M. Aldea, S. Waqar, K. Pepin, J. Ward, A. Botticella, K. Howarth, C. Knape, C. Morris, R. Govindan, B. Besse, D. Morgensztern Read More
Clinical utility of TP53 mutations (TP53m) dynamic monitoring in circulating tumor DNA (ctDNA) in patients (pts) with high-grade ovarian carcinomas (HGOC)
Event name - ESMO Virtual 2020
M. Kfoury, C.Bonnet, N.Delanoy, C. Brizais, A. Leformal, K. Howarth, C. Morris, E. Lecerf, A. Leary Read More
Circulating tumor DNA genomics reveals potential mechanisms of resistance to BRAF-targeted therapies in BRAF-mutant metastatic non-small cell lung cancer patients
Event name - Clinical Cancer Research 2020
Sandra Ortiz-Cuaran, Laura Mezquita, Aurélie Swalduz, Mihaela Aldea, Julien Mazieres, Camille Leonce, Cecile Jovelet, Anne Pradines, Virginie Avrillon, Washington René Chumbi Flores, Ludovic Lacroix, Yohann Loriot, Virginie Westeel, Maud Ngo-Camus, Claire Tissot, Christine Raynaud, Radj Gervais, Etienne Brain, Isabelle Monnet, Etienne Giroux Leprieur, Caroline Caramella, Celine Mahier-Aït Oukhatar, Natalie Hoog-Labouret, Frank de Kievit, Karen Howarth, Clive Morris, Emma Green, Luc Friboulet, Sylvie Chabaud, Jean-François Guichou, Maurice Perol, Benjamin Besse, Jean-Yves Blay, Pierre Saintigny and David Planchard Read More
ctDNA detection in early-stage non-small cell lung cancer
Event name - AACR Virtual Annual Meeting II 2020
Katrin Heider, Jonathan C.M. Wan, Davina Gale - PRESENTING AUTHOR, Andrea Ruiz-Valdepenas, Florent Mouliere, James Morris, Wendi Qian, Jerome Wulff, Nikolaos Demiris, Karen Howarth, Emma Green, Viona Rundell, Tim Eisen, Wendy Cooper, Christopher G. Smith, Charles Massie, Susan Harden, Doris M. Rassl, Robert C. Rintoul, Nitzan Rosenfeld Read More
Sensitive detection of ctDNA in early-stage non-small cell lung cancer patients with a personalized sequencing assay
Event name - AACR Virtual Annual Meeting II 2020
Katrin Heider, Davina Gale - PRESENTING AUTHOR, Andrea Ruiz-Valdepenas, Giovanni Marsico, Garima Sharma, Malcolm Perry, Peter Ellis, Robert Osborne, Karen Howarth, Tadd Lazarus, Viona Rundell, Jelena Belic, Jerome Wulff, Susan Harden, Doris M. Rassl, Robert C. Rintoul, Nitzan Rosenfeld Read More
Analytical development of the RaDaR™ assay, a highly sensitive and specific assay for the monitoring of minimal residual disease
Event name - AACR Virtual Annual Meeting II 2020
Giovanni Marsico, Garima Sharma, Malcolm Perry, Sophie Hackinger, Tim Forshew, Karen Howarth, Peter Ellis, Katrin Heider, Davina Gale, Robert C. Rintoul, Jamie Platt, Nitzan Rosenfeld, Robert Osborne Read More
Exploitation of Treatment Induced Tumor Lysis to Enhance Sensitivity of ctDNA Analysis: A First-In-Human Pilot Study
Event name - AACR Virtual Annual Meeting II 2020
Breadner, D., Vincent, M., Correa, R., Black, M., Warner, A., Qu, M., Logan, D., Sanatani, M., Younus, J., Yaremko, B., Rodrigues, G., Blanchette, P., Bhat, V., Morris, C., Green, E., Jones, G., Allan, A., Palma, D., Raphael, J. Read More
Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay
Event name - PLOS ONE
Jordi Remon, Aurelie Swalduz, David Planchard, Sandra Ortiz-Cuaran, Laura Mezquita, Ludovic Lacroix, Cecile Jovelet, Etienne Rouleau, Camille Leonce, Frank De Kievit, Clive Morris, Greg Jones, Kelly Mercier, Karen Howarth, Emma Green, Maurice Pérol, Pierre Saintigny, Benjamin Besse Read More
Early plasma circulating tumor DNA (ctDNA) changes to predict response to first-line pembrolizumab +/- chemotherapy in non-small cell lung cancer (NSCLC)
Event name - ASCO20 Virtual
Biagio Ricciuti, Christine Champagne, Greg Jones, Tadd Scott Lazarus, Anika E. Adeni, Michael L. Cheng, Geoffrey R. Oxnard, Mark M. Awad Read More
Exploitation of treatment induced tumor lysis to enhance sensitivity of ctDNA analysis: A first-in-human pilot study
Event name - ASCO20 Virtual
Daniel Adam Breadner, Mark David Vincent, Rohann Jonathan Mark Correa, Morgan Black, Andrew Warner, Melody Qu, Diane Logan, Michael Susmoy Sanatani, Jawaid Younus, Brian P Yaremko, George Rodrigues, Phillip S. Blanchette, Joanna Laba, Vasudeva Bhat, Clive D. Morris, Emma Green, Greg Jones, Alison L Allan, David A. Palma, Jacques Raphael Read More
Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting ALK and ROS1 Fusion and Resistance Mutations in Patients With Non–Small-Cell Lung Cancer
Event name - JCO Precision Oncology 2020
Laura Mezquita, MD, PhD; Aurélie Swalduz, MD, Cécile Jovelet, PhD; Sandra Ortiz-Cuaran, PhD; Karen Howarth, PhD; David Planchard, MD, PhD; Virginie Avrillon, MD; Gonzalo Recondo, MD, PhD; Solène Marteau, BSc; Jose Carlos Benitez, MD; Frank De Kievit, BSc; Vincent Plagnol, PhD; Ludovic Lacroix, PharmD, PhD; Luc Odier, MD; Etienne Rouleau, PharmD, MPH, PhD; Pierre Fournel, MD, PhD; Caroline Caramella, MD; Claire Tissot, MD; Julien Adam, MD, PhD; Samuel Woodhouse, PhD; Claudio Nicotra, BSc; Edouard Auclin, MD; Jordi Remon, MD; Clive Morris, MD; Emma Green, BSc; Christophe Massard, MD, PhD; Maurice Pérol, MD; Luc Friboulet, PhD; Benjamin Besse, MD, PhD and Pierre Saintigny, MD, PhD. Read More
Circulating tumor DNA analysis for patients with oncogene-addicted NSCLC with isolated central nervous system progression
Event name - Journal of Thoracic Oncology
Mihaela Aldea MD, PhD, Lizza Hendriks MD, PhD, Laura Mezquita MD, PhD, Cécile Jovelet PharmD, PhD, David Planchard MD, PhD, Edouard Auclin MD, PhD, Jordi Remon MD, Karen Howarth PhD, Jose Carlos Benitez MD, Anas Gazzah MD , Pernelle Lavaud MD, Charles Naltet MD, Ludovic Lacroix PharmD, PhD, Frank de Kievit BAS, Clive Morris MD, MBA, Emma Green, Maud Ngo-Camush, Etienne Rouleau PharmD, PhD and Benjamin Besse MD, PhD Read More
Role of circulating tumor DNA (ctDNA) from Liquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation (LIBERTI)
Event name - AACR Advances in Liquid Biopsies Conference 2020
Daniel Morgensztern, Emma Green, Jennifer C. King, Alicia Sable-Hunt, Richard Erwin, Amy Moore, Tony Addario, Clive Morris, Ramaswamy Govindan Read More
Clinical utility of ctDNA genomic alterations (GA) based on ESMO scale for clinical actionability of molecular targets (ESCAT) in advanced NSCLC
Event name - ESMO Asia 2019
L. Mezquita, D. Planchard, M. Dorta, M. Aldea, C. Naltet, V. Lamberts, M. Grecea, P. Martin-Romano, F. de Kievit, C. Jovelet, E. Rouleau, L. Lacroix, J. Remon, P. Lavaud, A. Gazzah, C. Morris, K. Howarth, E. Green, G. Vassal, C. Massard and B. Besse Read More
Clinical utility of ctDNA driver Genomic Alterations (GA) directing targeted therapy in untreated advanced NSCLC patients
Event name - North America Conference on Lung Cancer 2019
L. Mezquita, D. Planchard, M. Dorta, M. Aldea, C. Naltet, V. Lamberts, A.-M. Grecea, P. Martin-Romano, F. de Kievit, C. Jovelet, E. Rouleau, L. Lacroix, J. Remon, P. Lavaud, A. Gazzah, C. Morris, K. Howarth, E. Green, C. Massard, B. Besse Read More
Diverse resistance mechanisms to the third-generation ALK inhibitor lorlatinib in ALK-rearranged lung cancer
Event name - Clinical Cancer Research 2019
Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti, David Planchard, Anas Gazzah, Ludovic Bigot, Ahsan Z Rizvi, Rosa L Frias, Jean Paul Thiery, Jean-Yves Scoazec, Tony Sourisseau, Karen Howarth, Olivier Deas, Dariia Samofalova, Justine Galissant, Pauline Tesson, FlorianeBraye, Charles Naltet, Pernelle Lavaud, Linda Mahjoubi, Aurélie Abou Lovergne, Gilles Vassal, Rastilav Bahleda, Antoine Hollebecque, ClaudioNicotra, Maud Ngo-Camus, Stefan Michiels, Ludovic Lacroix, Catherine Richon, Nathalie Auger, Thierry De Baere, Lambros Tselikas, Eric Solary,Eric Angevin, Alexander M Eggermont, Fabrice Andre, Christophe Massard, Ken A Olaussen, Jean-Charles Soria, Benjamin Besse and LucFriboulet Read More
Circulating tumor DNA analysis reveals potential mechanisms of resistance to BRAF-targeted therapies in BRAF-mutant non-small cell lung cancer
Event name - ESMO 2019
Sandra Ortiz-Cuaran, Laura Mezquita, Aurélie Swalduz, Mihaela Aldea, Julien Mazières, Cecile Jovelet, Washington René Chumbi Flores, Ludovic Lacroix, Yohan Loriot, Luc Friboulet, Virginie Westeel, Maud Ngocamus, Anne Pradines, Claire Tissot, Christelle Clement Duchene, Christine Raynaud, Xavier Quantin, Radj Gervais, Etienne Brain, Isabelle Monnet, Etienne Giroux Leprieur, Virginie Avrillon, Céline Mahier-Aït Oukhatar, Natalie Hoog-Labouret, Frank de Kievit, Karen Howarth, Jean-François Guichou, Clive Morris, Emma Green, Maurice Pérol, Benjamin Besse, Jean-Yves Blay, Pierre Saintigny, David Planchard Read More
Improved ctDNA detection in early stage non-small cell lung cancer
Event name - CNAPS 2019
Katrin Heider, Jonathan CM Wan, Davina Gale, Andrea Ruiz-Valdepenas, Florent Mouliere, James Morris, Wendi Qian, Jerome Wulff, Nikolaos Demiris, Karen Howarth, Emma Green, Alexandra Williams, Tim Eisen, Christopher G Smith, Doris M. Rassl, Susan Harden, Robert C. Rintoul, Charles Massie, Nitzan Rosenfeld Read More
Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer
Event name - Lung Cancer Journal 2019
Nicolas Guibert, Greg Jones, John F. Beeler, Vincent Plagnol, Clive Morris, Jean Mourlanette, Myriam Delaunay, Laura Keller, Isabelle Rouquette, Gilles Favre, Anne Pradines, Julien Mazieres Read More
Circulating tumor DNA assay and survival in patients with metastatic, non-small cell lung cancer
Event name - WCLC 2019
Jennifer L. Ersek, Madeline Hosking, James Symanowski, Qing Zhang, Emma Green, Edward S. Kim Read More
Longitudinal circulating tumor DNA analysis in blood and saliva predicts response to osimertinib and disease progression in EGFR-mutant non-small-cell lung cancer
Event name - WCLC 2019
Chul Kim, Liqiang Xi, Constance M. Cultraro, Fang Wei, Gregory Jones, Jordan Cheng, Ahmad Shafiei, Trinh Hoc-Tran Pham, Nitin Roper, Elizabeth Akoth, Vikram Misra, Nina Monkash, Charles Strom, Michael Tu, Wei Liao, David Chia, Clive Morris, Seth M. Steinberg, Mohammadhadi Bagheri, David T.W. Wong, Mark Raffeld, Udayan Guha. Read More
Circulating tumor DNA (ctDNA) analysis for genomic testing in non small cell lung cancer (NSCLC) patients with isolated central nervous system progression (iCNS)
Event name - ASCO 2019
Mihaela Aldea, Laura Mezquita, Lizza Hendriks, Edouard Auclin, Jordi Remon, David Planchard, Cécile Jovelet, Jose Carlos Benitez, Anas Gazzah, Pernelle Lavaud, Charles Naltet, Ludovic Lacroix, Clive Morris, Emma Green, Karen Howarth, Claudio Nicotra and Benjamin Besse Read More
Efficacy of TKIs based on the ALK resistance mutations on amplicon-based liquid biopsy in ALK positive Non-Small Cell Lung Cancer (NSCLC) patients
Event name - ASCO 2019
L Mezquita, A Swalduz, C Jovelet, S Ortiz-Cuaran, D Planchard, G Recondo, JC Benitez, K Howarth, F de Kievit, C Morris, E Green, L Lacroix, L Odier, E Rouleau, P Fournel, C Caramella, C Tissot, C Nicotra, M Pérol, C Massard, L Friboulet, B Besse, P Saintigny Read More
Dynamic changes in circulating tumor DNA during chemoradiation for locally advanced lung cancer
Event name - Advances in Radiation Oncology
Michael N.Corradetti MD, PhD; Jordan A. Torok MD; Ace J.Hatch PhD; Eric P.Xanthopoulos MD; JD Kyle Lafata PhD; Corbin Jacobs MD; Christel Rushing MA; John Calaway PhD; Greg Jones MS; Chris R.Kelsey MD; Andrew B.Nixon PhD Read More
Prospective clinical validation of the InVisionFirst-Lung circulating tumor DNA assay for molecular profiling of patients with advanced Nonsquamous Non–Small-Cell Lung Cancer
Event name - JCO Precis Oncol. 2019
Michael A. Pritchett, D. Ross Camidge, Manu Patel, Jamil Khatri, Steven Boniol, Elke K. Friedman, Abderrahim Khomani, Samir Dalia, Katherine Baker-Neblett, Vincent Plagnol, Karen D. Howarth, Gregory R. Jones; Nitzan Rosenfeld, Clive D. Morris and Ramaswamy Govindan. Read More
Real-World utility of an amplicon-based next-generation sequencing Liquid Biopsy for Broad Molecular Profiling in patients with Advanced Non–Small-Cell Lung Cancer
Event name - JCO Precis Oncol. 2019
Jordi Remon; Ludovic Lacroix; Cecile Jovelet, Caroline Caramella, Karen Howarth, ; Vincent Plagnol, Nitzan Rosenfeld, Clive Morris, Laura Mezquita, Chloe Pannet; Maud Ngocamus; Cecile Le Pechoux, Julien Adam, Alina-Miruna Grecea, David Planchard, Gilles Vassal, Jose Carlos Benitez, Anas Gazzah, Emma Green; Jean-Charles Soria, and Benjamin Besse. Read More
Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced NSCLC
Event name - SITC/ASCO2019
Nicolas Guibert MD, Greg Jones, John Beeler PhD, Vincent Plagnol PhD, Jean Mourlanette, Myriam Delaunay MD, Anne Casanova, Gilles Favre PhD, Anne Pradines PhD and Julien Mazieres MD PhD Read More
ctDNA: A Novel Biomarker for Immunotherapy Response in Advanced Lung Cancer
Event name - SITC 2018
Meera Yogarajah, Ebenezer Ofori Appah, Katherine Baker Neblett, Clive D. Morris, Greg Jones, Vincent Plagnol and Paul R. Walker Read More
Early plasma ctDNA response anticipates clinical response to first-line immunotherapy in advanced NSCLC
Event name - WCLC 2018
Mark M. Awad, Biagio Ricciuti, Christine A. Lydon, Anika Adeni, Safiya Subegdjo, Greg Jones, Vincent Plagnol, John Beeler and Geoffrey R. Oxnard Read More
Prospective clinical validation of the InVisionFirst™ ctDNA assay for molecular profiling of patients with advanced NSCLC
Event name - WCLC 2018
Ramaswamy Govindan, Michael A. Pritchett, D. Ross Camidge, Manu Patel, Jamil Khatri, Steven Boniol, Elke K. Friedman, Abderrahim Khomani, Samir Dalia, Katherine Baker-Neblett, Vincent Plagnol, Karen Howarth, Nitzan Rosenfeld and Clive D. Morris Read More
Feasibility, clinical relevance of ALK/ROS1 fusion variant detection by liquid biopsy in advanced non-small cell lung cancer
Event name - WCLC2018
Aurélie Swalduz, Laura Mezquita, Sandra Ortiz-Cuaran, Cécile Jovelet, Virginie Avrillon, David Planchard, Solène Marteau, Gonzalo Recondo, Séverine Martinez, Frank De Kievit, Vincent Plagnol, Karen Howarth, Clive Morris, Emma Green, Luc Odier, Ludovic Lacroix, Pierre Fournel, Etienne Rouleau, Claire Tissot, Caroline Caramella, Stéphane Hominal, Luc Friboulet, Maurice Pérol, Benjamin Besse and Pierre Saintigny Read More
Prospective efficacy of osimertinib in circulating tumour DNA (ctDNA) T790M-mutant NSCLC patients
Event name - WCLC 2018
J.Remon, C. Jovelet, L. Lacroix, D. Planchard, L. Mezquita, K. Howarth,E. Green, V. Plagnol, C Morris, N Rosenfeld, C. Caramella, C. Le Péchoux C, F.Aboubakar Nana, E. Auclin, A. Botticella, J. Adam, R. Ferrara, A. Gazzah, M. Ngocamus, JC. Soria, B. Besse. Read More
Validation of InVisionFirst ctDNA NGS profiling via ddPCR testing in patients with Non-Small cell lung cancer (NSCLC)
Event name - WCLC 2018
Michael A. Pritchett, Katherine Baker-Neblett, Kathryn Finch Mileham, Vincent Plagnol, Karen Howarth, Tim Forshew, Greg Jones, Clive Morris Read More
Clinical relevance OF ALK/ROS1 resistance mutations and other acquired mutations detected by liquid biopsy in advanced NSCLC patients
Event name - WCLC 2018
L Mezquita, A Swalduz, C Jovelet, S Ortiz-Cuaran, David Planchard, V Avrillon, G Recondo, S Marteau, V Plagnol, K Howarth, C Morris, E Green, L Lacroix, L Odier, E Rouleau, P Fournel, C Caramella, C Tissot, Julien Adam, M Pérol, Luc Friboulet, Pierre Saintigny, B Besse Read More
Circulating Tumor DNA Analysis for Predicting Response to Osimertinib and Disease Progression in EGFR-Mutant Non-Small-Cell Lung Cancer
Event name - WCLC 2018
Chul Kim, Liqiang Xi, Constance M. Cultraro , Trinh Hoc-Pham Tran, Ahmad Shafei, Nitin Roper, Mohammadhadi Bagheri, John Beeler, Gregory Jones , Mark Raffeld and Udayan Guha Read More
TIMELY: Multicentre phase II trial of first-line afatinib in patients with suspected/confirmed EGFR mutant NSCLC – ctDNA and long-term efficacy
Event name - WCLC2018
Sanjay Popat, Adam Januszewski, Laura Hughes, Mary O’Brien, Tanya Ahmad, Conrad Lewanski, Ulrike Dernedde, Petra Jankowska, Clive Mulatero, Riyaz Shah, Jonathan Hicks,Tom Geldart, Mathilda Cominos, Gill Gray, James Spicer, Karen Bell, Simon Roitt, Karen Howarth, Mattia Cinelli, Emma Green, Clive Morris, Yenting Ngai, Allan Hackshaw Read More
Clinical outcomes in patients with advanced NSCLC treated with targeted therapies, with actionable mutations identified by InVisionFirstctDNA assay
Event name - MAP 2018
Jordi Remon, Sandra Ortiz-Cuaran, Laura Mezquita, Aurelie Swalduz, Karen Howarth, Cecile Jovelet, Ludovic Lacroix, Etienne Rouleau, Frank De Kievit, Katherine Baker-Neblett, Simon Roitt, Vincent Plagnol, Clive Morris, Emma Green, Maurice Perol, David Planchard, Pierre Saintigny, Benjamin Besse Read More
An Amplicon-Based Liquid Biopsy For Detecting ALK and ROS1 Fusions And Resistance Mutations In Advances Non-Small Cell Lung Cancer (NSCLC) Patients
Event name - ASCO 2018
L Mezquita, C Jovelet, L Lacroix, D Planchard, G Recondo, E Pailler, E Auclin, V Plagnol, K Howarth, C Morris, E Green, E Rouleau, C Nicotra, C Caramella, J Adam, N Auger, F Farace, L Friboulet, B Besse Read More
Early prediction of outcomes to PD1 inhibitors in non-small cell lung cancer using next generation sequencing of plasma circulating tumor DNA
Event name - ASCO 2018
Nicolas Guibert, MD, Greg Jones, John Beeler, PhD, Vincent Plagnol, PhD, Jean Mourlanette, Myriam Delaunaya, Anne Casanova, Gilles Favre, PhD, Anne Pradines, PhD, Julien Mazieres, MD, PhD Read More
Longitudinal circulating-tumor DNA profiling of EGFR-mutated non-small cell lung cancer patients treated with EGFR-tyrosine kinase inhibitors
Event name - AACR 2018 - Please contact us for more information on this poster
Sandra Ortiz-Cuaran, Aurélie Swalduz, Camille Léonce, Solène Marteau, Séverine Martinez, Gilles Clapisson, Virginie Avrillon, Luc Odier, Lionel Falchero, Pierre Fournel, Emma Green, Clive Morris, Maurice Pérol, Pierre Saintingy. Read More
Analytical validation of InVisionFirst™, a liquid biopsy assay for high-sensitivity broad molecular profiling of circulating tumor DNA using plasma samples of cancer patients
Event name - AACR 2018 - Please contact us for more information on this presentation
Samuel Woodhouse, Vincent Plagnol, Karen Howarth, Stefanie Lensing, Matt Smith, Michael Epstein, Mikidache Madi, Sarah Smalley, Catherine Leroy, Jonathan Hinton, Frank de Kievit, Esther Musgrave-Brown, Colin Herd, Katherine Baker-Neblett, Will Brennan, Peter Dimitrov, Nathan Campbell, Nitzan Rosenfeld, James Clark, Davina Gale, Jamie Platt, John Calawa2, Greg Jones and Tim Forshew Read More
Feasibility of an amplicon-based liquid biopsy assay for ALK and ROS1 gene fusions in advanced non-small cell lung cancer patients
Event name - AACR 2018
L Mezquita, Y Hu, K Howarth, C Jovelet, D Planchard, L Lacroix, A Swalduz, S Ortiz-Cuaran, V Avrillon, V Plagnol K Baker-Neblett, G Jones, N. Rosenfeld, C Morris, E Green, ES Kim, M Perol, P Saintigny, SV Liu, GR Oxnard, B Besse Read More
Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling
Event name - PLOS ONE 2018
Vincent Plagnol, Samuel Woodhouse, Karen Howarth, Stefanie Lensing, Matt Smith, Michael Epstein, Mikidache Madi, Sarah Smalley, Catherine Leroy, Jonathan Hinton, Frank de Kievit, Esther Musgrave-Brown, Colin Herd, Katherine Baker-Neblett, Will Brennan, Peter Dimitrov, Nathan Campbell, Clive Morris, Nitzan Rosenfeld, James Clark, Davina Gale, Jamie Platt, John Calaway, Greg Jones, Tim Forshew Read More
Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA
Event name - PLOS ONE 2018
Davina Gale , Andrew R. J. Lawson, Karen Howarth, Mikidache Madi, Bradley Durham, Sarah Smalley, John Calaway, Shannon Blais, Greg Jones, James Clark, Peter Dimitrov, Michelle Pugh, Samuel Woodhouse, Michael Epstein, Ana Fernandez-Gonzalez, Alexandra S. Whale, Jim F. Huggett, Carole A. Foy, Gerwyn M. Jones, Hadas Raveh-Amit, Karin Schmitt, Alison Devonshire, Emma Green, Tim Forshew, Vincent Plagnol, Nitzan Rosenfeld Read More
Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer
Event name - Annals of Oncology 2018
Nicolas M. Guibert, Yuebi Hu, Nora Feeney, Vincent Plagnol, Greg Jones, Karen Howarth, John Beeler, Cloud P. Paweletz, Geoffrey R. Oxnard Read More
Evaluation of stored liquid biopsies for molecular profiling in non-small cell lung cancer (NSCLC) patients
Event name - ASCO 2017
Penelope A. Bradbury, Keyue Ding, Peter M. Ellis, Lesley Seymour, Frank De Kievit, Greg Jones, Clive Morris, Emma, Green, Glenwood D. Goss, Ming Sound Tsao, Frances A. Shepherd Read More
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Event name - Nature Reviews Cancer 2017
Jonathan C. M. Wan, Charles Massie, Javier Garcia-Corbacho, Florent Mouliere, James D. Brenton, Carlos Caldas, Simon Pacey, Richard Baird and Nitzan Rosenfeld Read More
Evaluation of liquid biopsies for molecular profiling in advanced non-small cell lung cancer (NSCLC) patients in the relapse treatment setting
Event name - ASCO 2017
Remon J, Besse B, Lacroix L, Mezquita L, Jovelet C, Howarth K, Plagnol V, Morris C, Nicotra C, Pannet C, Green E, Soria JC Read More
Comparison of enhanced Tagged-Amplicon Sequencing and digital PCR for circulating tumor DNA analysis in advanced breast cancer
Event name - AACR 2017
Isaac Garcia-Murillas, Matthew Beaney, Michael Epstein, Karen Howarth, Andrew Lawson, Sarah Hrebien, Emma Green, Nitzan Rosenfeld and Nicholas C. Turner Read More
Evaluation of liquid biopsies for molecular profiling in untreated advanced non-small cell lung cancer (NSCLC) patients
Event name - ASCO 2017
Besse B, Remon J, Lacroix L, Mezquita L, Jovelet C, Howarth K, Plagnol V, Morris C, Nicotra C, Pannet C, Green E, Soria JC. Read More
Amplicon-based next-generation sequencing (NGS) of plasma cell-free DNA (cfDNA) for detection of driver and resistance mutations in advanced NSCLC
Event name - WCLC 2017
Nicolas M. Guibert, Yuebi Hu, Nora Feeney, Michael Epstein, Samuel Woodhouse, Karen Howarth, Vincent Plagnol, John Beeler, Greg Jones, Cloud P. Paweletz, Geoffrey R. Oxnard Read More
Molecular profiling of advanced pancreatic cancer (PC) patients from a phase I/II study using circulating tumor DNA
Event name - ASCO 2017
Catenacci DVT, Green E, Epstein M, Jones G, Morris C, O’Day E, Lomnicki S, Maranto M, Karrison T, Kindler Read More
Liquid biopsies for monitoring brafv600e mutation in advanced brafv600e non-small cell lung cancer (NSCLC)
Event name - WCLC 2017
Laura Mezquita, Cecile Jovelet, Maud Ngocamus, Edouard Auclin, Jordi Remon, Emma Green, Vincent Plagnol, Clive Morris, Anas Gazzah, Caroline Caramella, Julien Adam, Ludovic Lacroix, Luc Friboulet, Jean-Charles Soria, Benjamin Besse, David Planchard Read More
Early detection of competing resistance mutations using plasma next-generation sequencing in patients with EGFR-mutant NSCLC treated with osimertinib
Event name - ASCO 2017
Nicolas M Guibert, Cloud Paweletz, Yuebi Hu, Nora Feeney, Vincent Plagnol, Valerie Poole, Greg Jones, Geoffrey Oxnard Read More
Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer
Event name - Annals of Oncology 2017
Charlotte Fribbens, Isaac Garcia Murillas, Matthew Beaney, Sarah Hrebien, Ben O’Leary, Lucy Kilburn, Karen Howarth, Michael Epstein, Emma Green, Nitzan Rosenfeld, Alistair Ring, Stephen Johnston, Nicholas Turner Read More
Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA
Event name - Annals of Oncology 2017
J. Remon, C. Caramella, C. Jovelet, L. Lacroix, A. Lawson, S. Smalley, K. Howarth, D. Gale, E. Green, V. Plagnol, N. Rosenfeld, D. Planchard, M. V. Bluthgen, A. Gazzah, C. Pannet, C. Nicotra, E. Auclin, J. C. Soria and B. Besse Read More
Tracking evolution of aromatase inhibitor resistance with circulating tumor DNA in metastatic breast cancer
Event name - ASCO 2017
Charlotte Fribbens, Isaac Garcia-Murillas, Matthew Beaney, Sarah Hrebien, Karen Howarth, Michael Epstein, Nitzan Rosenfeld, Alistair Ring, Stephen Johnston and Nicholas C. Turner Read More
Analytical performance and validation of an InVision® circulating tumour DNA sequencing assay across two laboratories
Event name - WCLC 2016
Tim Forshew, Andrew Lawson, Sarah Smalley, Vincent Plagnol, John Calaway, Shannon Blais, Karen Howarth, Greg Jones, Michelle Pugh, Mikidache Madi, Bradley Durham, Esther Musgrave-Brown, Samuel Woodhouse, Nitzan Rosenfeld, Davina Gale, Emma Green and James Clark Read More
Evaluation of liquid biopsies for molecular profiling and monitoring in advanced non-small cell lung cancer (NSCLC) patients
Event name - ASCO 2016
Remon J, Soria JC, Lacroix L, Howarth K, Lawson A, Smalley S, Gale D, Plagnol V, Green E, Rosenfeld N, Planchard D, Jovelet C, Pannet C, Besse B Read More
Analytical performance and validation of an enhanced TAm-Seq™ circulating tumour DNA sequencing assay across two laboratories
Event name - NCRI 2016
Karen Howarth, John Calaway, Sarah Smalley, Shannon Blais, Andrew Lawson, Greg Jones, Davina Gale, Michelle Pugh, Mikidache Madi, Bradley Durham, Esther Musgrave-Brown, Samuel Woodhouse, Tim Forshew, Emma Green, Vincent Plagnol, Nitzan Rosenfeld and James Clark Read More
Liquid biopsies for molecular profiling of mutations in non-small cell lung cancer (NSCLC) patients lacking tissue samples
Event name - AACR 2016
Remon J, Soria JC, Planchard D, Jovelet C, Pannet C, Lacroix L, Gazzah A, Lawson A, Smalley S, Howarth K, Gale D, Green E, Plagnol V, Rosenfeld N, Olaussen K, Chaput N, Besse B Read More
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
Event name - PLOS Medicine 2016
Christine A. Parkinson, Davina Gale, Anna Piskorz, Heather Biggs, Charlotte Hodgkin, Helen Addley, Sue Freeman, Penelope Moyle, Evis Sala, Karen Sayal, Karen Hosking, Ioannis Gounaris, Mercedes Jimenez-Linan, Helena M. Earl, Wendi Qian, Nitzan Rosenfeld, James Brenton Research was conducted through CRUK, not Inivata. Read More
Analytical performance and validation of an enhanced TAm-Seq™ circulating tumor DNA sequencing assay
Event name - AACR 2016
Davina Gale, Vincent Plagnol, Andrew Lawson, Michelle Pugh, Sarah Smalley, Karen Howarth, Mikidache Madi, Bradley Durham, Vasudev Kumanduri, Kitty Lo, Peter Dimitrov, Jordi Remon, Benjamin Besse, James Clark, Emma Green, Nitzan Rosenfeld, Tim Forshew Read More
Osimertinib benefit in ctDNA T790Mpositive, EGFR-mutant NSCLC patients
Event name - WCLC 2016
Remon J, Caramella C, Jovelet C, Lacroix L, Lawson A, Smalley S, Howarth K, Gale D, Rosenfeld N, Green E, Plagnol V, Planchard D, Bluthgen MV, Gazzah A, Pannet C, Nicotra C, Soria JC, Besse B Read More
Liquid biopsies for molecular profiling of mutations in non-small cell lung cancer (NSCLC) patients lacking tissue samples
Event name - MAP 2016
Remon J, Soria JC, Planchard D, Jovelet C, Pannet C, Lacroix L, Gazzah A, Lawson A, Smalley S, Howarth K, Gale D, Green E, Plagnol V, Rosenfeld N, Oulassen K, Besse B Read More
Assessing the clinical applications of ctDNA in patients with advanced stage metastatic cancer using our enhanced TAm-Seq™platform
Event name - Molecular Targets and Cancer Therapeutics 2015
Sarah Smalley, Davina Gale, Andrew RJ Lawson, Jordi Remon, Esperanza Perez, Michelle Pugh, Karen D Howarth, Mehdi Touat, Jean-Charles Soria, Antoine Hollebecque, Emma Green, Benjamin Besse, Tim Forshew, Vincent Plagnol, Ludovic Lacroix, Nitzan Rosenfeld Read More
Assessment of clinical applications of circulating tumour DNA in lung cancer using an enhanced TAm-Seq™ platform
Event name - International Association for the Study of Lung Cancer Conference 2015
Davina Gale, Jordi Remon, Andrew RJ Lawson, Sarah Smalley, Esperanza Perez, Karen D Howarth, Michelle Pugh, Abdelaziz Fahem, Tim Forshew, Amanda Bettison, John Beeler, Ludovic Lacroix, Emma Green, Michael Stocum, Vincent Plagnol, Benjamin Besse, Nitzan Rosenfeld Read More
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Event name - Nature 2013 PubMed PMID: 23563269
Murtaza M, Dawson SJ, Tsui DW, Gale D, Forshew T, Piskorz AM, Parkinson C, Chin SF, Kingsbury Z, Wong AS, Marass F, Humphray S, Hadfield J, Bentley D, Chin TM, Brenton JD, Caldas C, Rosenfeld N. Read More
Analysis of circulating tumor DNA to monitor metastatic breast cancer
Event name - N Engl J Med. 2013 PubMed PMID: 23484797
Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, Dunning MJ, Gale D, Forshew T, Mahler-Araujo B, Rajan S, Humphray S, Becq J, Halsall D, Wallis M, Bentley D, Caldas C, Rosenfeld N. Read More
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Event name - Sci Transl Med. 2012 PubMed PMID: 22649089
Forshew T, Murtaza M, Parkinson C, Gale D, Tsui DW, Kaper F, Dawson SJ, Piskorz AM, Jimenez-Linan M, Bentley D, Hadfield J, May AP, Caldas C, Brenton JD, Rosenfeld N. Read More
Clinical validation and utility of InVision ctDNA in advanced non-small cell lung cancer (NSCLC) patients
Event name - MAP 2018
Jordi Remon, Laura Mezquita, David Planchard, Cecile Jovelet, Ludovic Lacroix, Etienne Rouleau, Karen Howarth, Vincent Plagnol, Clive Morris, Emma Green, Cecile LePechoux, Caroline Caramella, Julien Adam, Benjamin Besse Read More
